• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎牛血清对乳腺癌细胞促红细胞生成素受体表达及活力的影响。

Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells.

作者信息

Teo Guan-Young, Rasedee Abdullah, Al-Haj Nagi A, Beh Chaw Yee, How Chee Wun, Rahman Heshu Sulaiman, Alitheen Noorjahan Banu, Rosli Rozita, Abdullah Al-Shwyeh Hussah, Ali Abdelwahid Saeed

机构信息

Institute of Bioscience, Universiti Putra Malaysia, Malaysia.

Faculty of Veterinary Medicine, Universiti Putra Malaysia, Malaysia.

出版信息

Saudi J Biol Sci. 2020 Feb;27(2):653-658. doi: 10.1016/j.sjbs.2019.11.032. Epub 2019 Dec 6.

DOI:10.1016/j.sjbs.2019.11.032
PMID:32210684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6997850/
Abstract

Erythropoietin receptors (EPORs) are present not only in erythrocyte precursors but also in non-hematopoietic cells including cancer cells. In this study, we determined the effect of fetal bovine serum (FBS) in culture medium on the EPOR expression and viability of the estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Using flow cytometry, we showed that the inclusion of 10% FBS in the medium increased the EPOR expressions and viabilities of MDA-MB-231 and MCF-7 cells. The MDA-MB-231 showed greater EPOR expression than MCF-7 cells, suggesting that the presence of ERs on cells is associated with poor expression of EPOR. Culture medium containing 10% FBS also caused increased number of breast cancer cells entering the synthesis phase of the cell cycle. The study also showed that rHuEPO treatment did not affect viability of breast cancer cells. In conclusion, it was shown that the inclusion of FBS in culture medium increased expression of EPOR in breast cancer cells and rHuEPO treatment had no effect on the proliferation of these cancer cells.

摘要

促红细胞生成素受体(EPORs)不仅存在于红细胞前体中,还存在于包括癌细胞在内的非造血细胞中。在本研究中,我们测定了培养基中的胎牛血清(FBS)对雌激素受体(ER)阳性的MCF-7和ER阴性的MDA-MB-231乳腺癌细胞的EPOR表达及活力的影响。通过流式细胞术,我们发现培养基中加入10% FBS可增加MDA-MB-231和MCF-7细胞的EPOR表达及活力。MDA-MB-231细胞的EPOR表达高于MCF-7细胞,这表明细胞上ER的存在与EPOR的低表达有关。含有10% FBS的培养基还导致进入细胞周期合成期的乳腺癌细胞数量增加。该研究还表明,重组人促红细胞生成素(rHuEPO)处理不影响乳腺癌细胞的活力。总之,研究表明培养基中加入FBS可增加乳腺癌细胞中EPOR的表达,而rHuEPO处理对这些癌细胞的增殖没有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/d1535f1188ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/73a1abc6f028/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/ef0a542baf2b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/616cccb41af4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/5676b9bb899a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/d1535f1188ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/73a1abc6f028/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/ef0a542baf2b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/616cccb41af4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/5676b9bb899a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/6997850/d1535f1188ff/gr5.jpg

相似文献

1
Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells.胎牛血清对乳腺癌细胞促红细胞生成素受体表达及活力的影响。
Saudi J Biol Sci. 2020 Feb;27(2):653-658. doi: 10.1016/j.sjbs.2019.11.032. Epub 2019 Dec 6.
2
Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.重组人促红细胞生成素改变 MCF-7 乳腺癌细胞的基因表达并刺激其增殖。
Radiol Oncol. 2013 Oct 8;47(4):382-9. doi: 10.2478/raon-2013-0056. eCollection 2013.
3
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.在促红细胞生成素受体阳性乳腺癌模型中,重组促红细胞生成素不会刺激肿瘤生长。
Mol Cancer Ther. 2006 Feb;5(2):347-55. doi: 10.1158/1535-7163.MCT-05-0203.
4
Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.重组人促红细胞生成素可降低三维培养的MCF-7乳腺癌细胞的活力,且不激活半胱天冬酶。
Saudi J Biol Sci. 2021 Apr;28(4):2549-2557. doi: 10.1016/j.sjbs.2021.01.059. Epub 2021 Feb 11.
5
Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.不同乳腺癌细胞系中促红细胞生成素受体与雌激素和孕激素受体表达的相关性。
Int J Mol Med. 2013 Mar;31(3):717-25. doi: 10.3892/ijmm.2013.1231. Epub 2013 Jan 8.
6
Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.在原代造血祖细胞中组成型活性促红细胞生成素受体的表达消除了对促红细胞生成素的依赖性,并增强了红系集落形成单位、红系爆式集落形成单位以及粒细胞/巨噬细胞祖细胞的生长。
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):938-42. doi: 10.1073/pnas.90.3.938.
7
The Hydroalcoholic Extract of Suppresses Migration and Invasion of Human Breast Cancer MDA-MB-468 and MCF-7 Cell Lines.的水醇提取物抑制人乳腺癌MDA-MB-468和MCF-7细胞系的迁移和侵袭。 (注:原文中“The Hydroalcoholic Extract of ”后面缺少具体物质名称)
Pharmacognosy Res. 2017 Jan-Mar;9(1):87-95. doi: 10.4103/0974-8490.199778.
8
Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.Erythropoietin 受体表达及其与曲妥珠单抗反应和耐药性在 HER2 阳性乳腺癌细胞中的关系。
Breast Cancer Res Treat. 2012 Dec;136(3):739-48. doi: 10.1007/s10549-012-2316-x. Epub 2012 Nov 2.
9
P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.P2Y2 受体介导的雌激素诱导的乳腺癌细胞增殖的调节作用。
Mol Cell Endocrinol. 2011 May 16;338(1-2):28-37. doi: 10.1016/j.mce.2011.02.014. Epub 2011 Feb 26.
10
A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.一种导致家族性红细胞增多症的人类促红细胞生成素受体基因突变体与Jak2和Stat5失活速率的失调有关。
Exp Hematol. 1999 Jan;27(1):63-74. doi: 10.1016/s0301-472x(98)00003-4.

引用本文的文献

1
Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.重组人促红细胞生成素可降低三维培养的MCF-7乳腺癌细胞的活力,且不激活半胱天冬酶。
Saudi J Biol Sci. 2021 Apr;28(4):2549-2557. doi: 10.1016/j.sjbs.2021.01.059. Epub 2021 Feb 11.
2
Hypermethylation of dihydrofolate reductase promoter increases the risk of hypertension in Chinese.二氢叶酸还原酶启动子的高甲基化会增加中国人患高血压的风险。
J Res Med Sci. 2020 Dec 30;25:117. doi: 10.4103/jrms.JRMS_895_19. eCollection 2020.

本文引用的文献

1
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective.促红细胞生成素在慢性肾脏病或癌症贫血管理中的应用:历史视角
Front Pharmacol. 2019 Jan 9;9:1498. doi: 10.3389/fphar.2018.01498. eCollection 2018.
2
Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells.Hsp70(HSP70A1A)下调增强癌细胞的转移能力。
Int J Oncol. 2019 Mar;54(3):821-832. doi: 10.3892/ijo.2018.4666. Epub 2018 Dec 12.
3
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia.
治疗化疗引起的贫血和慢性肾脏病贫血的短效和长效红细胞生成刺激剂的疗效、安全性、经济学和健康相关生活质量结局的快速范围综述。
Crit Rev Oncol Hematol. 2018 Sep;129:79-90. doi: 10.1016/j.critrevonc.2018.06.010. Epub 2018 Jun 19.
4
Erythropoietin and Its Angiogenic Activity.促红细胞生成素及其血管生成活性。
Int J Mol Sci. 2017 Jul 13;18(7):1519. doi: 10.3390/ijms18071519.
5
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.促红细胞生成素通过激活其受体EPOR来推动乳腺癌进展。
Oncotarget. 2017 Jun 13;8(24):38251-38263. doi: 10.18632/oncotarget.16368.
6
Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers.使用载有他莫昔芬的纳米结构脂质载体开发针对乳腺癌的促红细胞生成素受体靶向给药系统。
Drug Des Devel Ther. 2017 Mar 14;11:771-782. doi: 10.2147/DDDT.S123939. eCollection 2017.
7
Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.正常和紊乱的人类红细胞生成中红系祖细胞的特征、调控及靶向作用
Curr Opin Hematol. 2017 May;24(3):159-166. doi: 10.1097/MOH.0000000000000328.
8
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.在从人乳腺、非小细胞肺癌、结肠直肠癌和卵巢肿瘤组织中分离出的原发性肿瘤细胞中未检测到功能性促红细胞生成素受体(EpoR)途径的利用情况。
PLoS One. 2015 Mar 25;10(3):e0122149. doi: 10.1371/journal.pone.0122149. eCollection 2015.
9
Effect of evodiagenine mediates photocytotoxicity on human breast cancer cells MDA-MB-231 through inhibition of PI3K/AKT/mTOR and activation of p38 pathways.吴茱萸次碱介导的光细胞毒性通过抑制PI3K/AKT/mTOR和激活p38信号通路对人乳腺癌细胞MDA-MB-231产生影响。
Fitoterapia. 2014 Dec;99:292-9. doi: 10.1016/j.fitote.2014.10.010. Epub 2014 Oct 16.
10
Erythropoietin and cancer: the unintended consequences of anemia correction.促红细胞生成素与癌症:纠正贫血的意外后果。
Front Immunol. 2014 Nov 11;5:563. doi: 10.3389/fimmu.2014.00563. eCollection 2014.